Notably, early recurrence within 2 years after surgery has been confirmed as an independent risk factor for treatment failure and poor prognosis, which may be related to alpha-fetoprotein (AFP), tumor size, and microvascular invasion (MVI) [3, 4]. This evidence concerns the gene AFP and neoplasm.